body fat for men, 25.0 76.9% and for women, 36.0 73.3%) were analysed. All patients were originally prescribed low-protein diets and energy according to NKF-K/DOQI recommendations. One month later, their body mass index, creatinine, urea and creatinine clearance (calculated by Cockcroft-Gault) were evaluated (Table) . The patients reported good adherence diet in clinical records. In spite of the short period of time, the dietary protein restriction during conservative treatment seems slowing the progression of kidney disease.
Understanding the physical and psychological status in patients with the end-stage renal disease (ESRD) on renal dialysis treatment (RDT) is a current issue of high importance due to a rising number of elderly patients. The aims of the study in ESRD patients were: 1) to test physical and psychological functions; 2) to propose suitable physical activities. Group of patients: (M/F,n¼ 34/33, age 67.0 7 12.7yrs/64.0 713.1yrs). For testing we used Senior Fitness Test Manual, KDQOL-SF TM -questionnaire SF36, WHOQOL-BREF, Importance of quality of the life (QoL) -WHOQOL-100. Results were analysed using descriptive statistics and non-parametric Wilcoxon signed-rank test.
In general, both the physical and psychological conditions were severely deteriorated in most components as compared to the non-renal population. Physical fitness was below the normal range of standard values, or to its lower limits, particularly in the tests requiring some degree of muscular strength of the lower limbs and physical efficiency. QoL results showed that in SF36 ESRD patients coincided with the normal range only in the domain of EWB-mental health. The questionnaire WHOQOL-BREF showed that QoL was: significantly lower in ESRD patients than in healthy population only in the domain ''physical health''. The most important domains of WHOQOL-100 were the domain of ''independence'' (the ability to take care of everyday needs -4.5 and the ability to move -4.3), ''environment'' (especially items related to the quality of health care -4.4).
The ESRD patients, especially the elderly, should be encouraged to pay attention to increased physical activity levels in order to maintain functional independence and high quality of the life for as long as possible. Wasting, cardiovascular complications and inflammation are known risk factors associated with high mortality in patients with chronic kidney disease (CKD). Ghrelin is an appetite-regulating hormone with additional effects in the modulation of systemic inflammation and the cardiovascular system. CKD patients with low serum ghrelin have high mortality risk and may benefit the most from ghrelin therapy.
Aim to investigate the effects of ghrelin on cachexia, muscle wasting, cardiovascular complications, inflammation and mortality in CKD.
C56BL/6J mice underwent 2-stage 5/6 nephrectomy (CKD) or sham operation (S). Ghrelin (150 nmole/kg/day) or saline was given to CKD or S mice. Over 90-days, mortality rates of 9 month old ghrelin-treated CKD mice (15%) and S mice (0%) were significantly better than those of CKD mice (57.5%). The cumulative food intake of the CKD þ ghrelin mice was significantly increased than CKD mice (po 0.01). CKD þ ghrelin mice gained more weight than CKD mice (p o0.01). CKD þ ghrelin mice gained lean body mass and fat mass while CKD mice lost lean and fat mass (po 0.01). 24 hr metabolic rate was increased and efficiency of food consumption was decreased in CKD mice as compared to S mice (po 0.001). Ghrelin normalized these abnormalities in CKD mice (po 0.01).
Ghrelin significantly improved systolic hypertension in CKD mice (po 0.01). Left ventricular hypertrophy (LVH) was ameliorated in CKD þghrelin mice as compared to CKD mice (po 0.01). TNF-a and IL-6 mRNA levels were significantly increased in gastrocnemius and cardiac muscles of CKD mice and ghrelin significantly decreased the expression of these inflammatory cytokines in CKD mice (po 0.01).
Our studies indicate that ghrelin ameliorates wasting, systemic hypertension and LVH with associated improvement in inflammation and mortality in CKD. Malnutrition is highly prevalent among haemodialysis patients, but the best method for assessing nutritional status remains unclear. Historically, Dietitians' use the Subjective Global Assessment (SGA) or Patient Generated Subjective Global Assessment (PG-SGA) tool to assess nutritional status of in centre haemodialysis patients. In 2001 a new tool called the Malnutrition Inflammation Score (MIS) was developed by Zadeh et al.
We conducted an annual malnutrition audit on patients who regularly attend the in-centre haemodialysis units at Gold Coast Hospital District using MIS and SGA/PG-SGA.
An annual malnutrition audit was conducted over a 2 month period with 100 in centre Haemodialysis patients across 2 centres. For each patient a nutritional assessment was conducted using SGA or PG-SGA and MIS assessment tool. The MIS tool was adapted to suit Australian laboratory measurements and units (Alb, TIBC); and the BMI scale adapted to be inline with current guideline recommendations.
Overall the malnutrition rate using PG-SGA/SGA was 28% of patients classified as ''malnourished'' (26% scored B-moderate malnutrition and 2% scored C-severe malnutrition). According to MIS the rate of malnutrition was 94% (39%-mild malnutrition; 22% moderate malnutrition; 33% severe malnutrition).
In conclusion there is discrepancy in the rate of malnutrition when assessed according to different tools. MIS has been shown to be a better predictor of survival in dialysis patients. We need interventional studies to assess the utility of MIS in improving patient outcome and survival in dialysis patients Many chronic kidney disease (CKD) patients experience uraemic symptoms including dry mouth, taste changes, nausea, vomiting and dry retching. Saliva is composed of a number of active compounds that play vital roles in taste stimulation. Salivary composition differs in CKD and patients have an impaired ability to recognise basic tastes. The purpose of this cross-sectional study was to determine any associations between changes in salivary composition, upper gastrointestinal (GI) symptoms and altered taste perceptions in chronic renal failure patients.
Thirty CKD patients (24 males, 6 females, age 69.7 7 14.2yrs, glomerular filtration rate o25mL/min) were recruited from the Austin Health outpatient renal clinic. A saliva sample was collected to determine biochemical composition. Participants performed a taste identification task to assess perception of the five basic tastes and completed a symptom questionnaire regarding taste changes and upper GI symptoms experienced.
Only 3 (10%) CKD patients reported no upper GI symptoms while 63% complained of a dry mouth, 56% had a changes in taste, 30% complained of nausea and 20% vomited or dry retched. Saliva bicarbonate concentration was inversely related to both dry mouth (po0.003) and dry retching. (po0.01) Nausea was reported with higher saliva sodium levels (po0.03) and a higher saliva sodium/potassium ratio (po0.02). Correlation analysis revealed saliva bicarbonate concentration was inversely related to liking and intensity of glutamate taste and to the intensity of sour taste (po0.05). Salivary urea was linked to the perceived intensity of bitter taste (po0.05). Forty-three percent of patients indicated their symptoms contributed to decreased food intake.
In conclusion this study provides evidence that active compounds are present in the saliva and impact upper GI symptoms in CKD. In particular lower saliva concentrations of bicarbonate are associated with dry mouth and retching, while higher sodium levels and a greater sodium/potassium ratio are associated with nausea. Saliva bicarbonate and urea are associated with taste perception, especially for glutamate and may influence taste function. Further research is required to clearly establish if changing saliva composition improves uraemic symptoms, taste sensitivity and food intake in CKD patients. Serum albumin (s-Alb) is not reliable marker of nutritional status in maintenance hemodialysis (MHD) patients, because s-Alb levels are not only affected by nutritional intake but also other factors including inflammation, age, comorbidity and albumin loss to dialysate. In this study we evaluated the influence of albumin losses to dialysate on s-Alb levels.
The sixty-four patients who have received MHD were analyzed (39 males, 45 females; diabetes 14; mean age 65.5710.9 years; duration of HD treatment 13.276.8 years). All patients received four-hour HD session three times per week with ultra-pure dialysate. Pre-dialysis levels of s-Alb were measured at the first HD session in the week. Based on two-day dietary records and photographs, the accomplished dietitians calculated dietary energy intake (DEI) and dietary protein intake (DPI). LBM, fat mass and ECF/ TBW (as an index of fluid overload) were measured using BIA (Inbody 3.0) after the first post-dialysis. Albumin losses to dialysate were measured by collecting total amount of dialysate during one dialysis session.
The mean levels of s-Alb and albumin losses to dialysate were 3.4670.26 g/ dl (2.8-4.1) and 0.8771.03 g/session (0.00-4.84). The s-Alb levels were not correlated with albumin losses, but correlated with CRP, sex, age, DEI/post-BW and LBM. The multiple regression analysis with s-Alb levels showed CRP and sex were independent variables, but not DEI/post-BW, nPCR, Kt/Vurea, LBM, fat mass, ECF/TBW and Albumin losses (r¼0.61, po0.01).
In conclusion, pre-dialysis s-Alb levels were affected by, not albumin losses to dialysate, but sex and CRP reflecting the inflammatory status. The main cause of death among dialysis is cardiovascular. The development of atherosclerosis involves several classical risk factors such as diabetes mellitus, hypertension and dyslipidemia. Knowing their characteristics allows planning therapeutic actions aimed at reducing mortality. The aim was to characterize clinically a sample of HD patients. Forty-nine patients on HD for at least 6 months were included. Individuals with malignant disease, active inflammation, in use of omega-3 oil or anticoagulants were excluded. Clinical data were collected from medical records. Albumin, urea, creatinine, total cholesterol, triglycerides (TG), phosphorus and potassium were measured. The average age of patients (27 men and 22 women) was 49.9 7 14.3 years. The mean duration of the HD
